Sara Pichtchoulin1, Ingrid Selmeryd2, Elisabeth Freyhult3, Pär Hedberg1,4, Jonas Selmeryd1,4. 1. Department of Clinical Physiology, Västmanland County Hospital, Västerås, Sweden. 2. Department of Infectious Diseases, Västmanland County Hospital, Västerås, Sweden. 3. Department of Microbiology, Västmanland County Hospital, Västerås, Sweden. 4. Centre for Clinical Research, Uppsala University, Västmanland County Hospital, Västerås, Sweden.
Abstract
BACKGROUND: Due to a high incidence of cardiac implantable electronic device-associated infective endocarditis (CIED-IE) in cases of Staphylococcus aureus bacteremia (SAB) and high mortality with conservative management, guidelines advocate device removal in all subjects with SAB. We aimed to investigate the clinical course of SAB in patients with a CIED (SAB+CIED) in a Swedish county hospital setting and relate it to guideline recommendations. METHODS: All CIED carriers with SAB, excluding clinical pocket infections, in the County of Västmanland during 2010-2017 were reviewed retrospectively. RESULTS: There were 61 cases of SAB+CIED during the study period, and CIED-IE was diagnosed in 13/61 (21%) cases. In-hospital death occurred in 19/61 (31%) cases, 34/61 (56%) cases were discharged with CIED device retained, and 8/61 (13%) cases were discharged after device removal. Subjects dying during hospitalization were elderly and diseased. No events was seen if the CIED was removed. Among four discharged cases with conservatively managed CIED-IE one relapse occured. Among 30 cases discharged with retained CIED and no evidence of IE, 22/30 (73%) cases had an uneventful follow-up, whereas adverse events secondary to overlooked CIED-IE were likely in 1/30 (3%) cases and could not be definitely excluded in additionally 4/30 (13%) cases. CONCLUSIONS: During the study period, management became more active and prognosis improved. The heterogeneity within the population of SAB+CIED suggests that a management strategy based on an individual risk/benefit analysis could be an alternative to mandatory device removal.
BACKGROUND: Due to a high incidence of cardiac implantable electronic device-associated infective endocarditis (CIED-IE) in cases of Staphylococcus aureus bacteremia (SAB) and high mortality with conservative management, guidelines advocate device removal in all subjects with SAB. We aimed to investigate the clinical course of SAB in patients with a CIED (SAB+CIED) in a Swedish county hospital setting and relate it to guideline recommendations. METHODS: All CIED carriers with SAB, excluding clinical pocket infections, in the County of Västmanland during 2010-2017 were reviewed retrospectively. RESULTS: There were 61 cases of SAB+CIED during the study period, and CIED-IE was diagnosed in 13/61 (21%) cases. In-hospital death occurred in 19/61 (31%) cases, 34/61 (56%) cases were discharged with CIED device retained, and 8/61 (13%) cases were discharged after device removal. Subjects dying during hospitalization were elderly and diseased. No events was seen if the CIED was removed. Among four discharged cases with conservatively managed CIED-IE one relapse occured. Among 30 cases discharged with retained CIED and no evidence of IE, 22/30 (73%) cases had an uneventful follow-up, whereas adverse events secondary to overlooked CIED-IE were likely in 1/30 (3%) cases and could not be definitely excluded in additionally 4/30 (13%) cases. CONCLUSIONS: During the study period, management became more active and prognosis improved. The heterogeneity within the population of SAB+CIED suggests that a management strategy based on an individual risk/benefit analysis could be an alternative to mandatory device removal.
Authors: Hai-Xia Fu; Xin-Miao Huang; L I Zhong; Michael J Osborn; Samuel J Asirvatham; Raul E Espinosa; Peter A Brady; Hon-Chi Lee; Kevin L Greason; Larry M Baddour; Rizwan M Sohail; Nancy G Acker; David O Hodge; Paul A Friedman; Yong-Mei Cha Journal: Pacing Clin Electrophysiol Date: 2015-09-22 Impact factor: 1.976
Authors: Fred M Kusumoto; Mark H Schoenfeld; Bruce L Wilkoff; Charles I Berul; Ulrika M Birgersdotter-Green; Roger Carrillo; Yong-Mei Cha; Jude Clancy; Jean-Claude Deharo; Kenneth A Ellenbogen; Derek Exner; Ayman A Hussein; Charles Kennergren; Andrew Krahn; Richard Lee; Charles J Love; Ruth A Madden; Hector Alfredo Mazzetti; JoEllyn Carol Moore; Jeffrey Parsonnet; Kristen K Patton; Marc A Rozner; Kimberly A Selzman; Morio Shoda; Komandoor Srivathsan; Neil F Strathmore; Charles D Swerdlow; Christine Tompkins; Oussama Wazni Journal: Heart Rhythm Date: 2017-09-15 Impact factor: 6.343
Authors: Shruti K Gohil; Chenghua Cao; Michael Phelan; Thomas Tjoa; Chanu Rhee; Richard Platt; Susan S Huang Journal: Clin Infect Dis Date: 2016-01-19 Impact factor: 9.079
Authors: V G Fowler; L K Kong; G R Corey; G S Gottlieb; R S McClelland; D J Sexton; D Gesty-Palmer; L J Harrell Journal: J Infect Dis Date: 1999-05 Impact factor: 5.226
Authors: Krishna Kancharla; Nancy G Acker; Zhuo Li; Swetha Samineni; Cheng Cai; Raul E Espinosa; Michael Osborn; Siva K Mulpuru; Samuel J Asirvatham; Paul A Friedman; Yong-Mei Cha Journal: JACC Clin Electrophysiol Date: 2019-02
Authors: Gilbert Habib; Patrizio Lancellotti; Manuel J Antunes; Maria Grazia Bongiorni; Jean-Paul Casalta; Francesco Del Zotti; Raluca Dulgheru; Gebrine El Khoury; Paola Anna Erba; Bernard Iung; Jose M Miro; Barbara J Mulder; Edyta Plonska-Gosciniak; Susanna Price; Jolien Roos-Hesselink; Ulrika Snygg-Martin; Franck Thuny; Pilar Tornos Mas; Isidre Vilacosta; Jose Luis Zamorano Journal: Eur Heart J Date: 2015-08-29 Impact factor: 29.983
Authors: Ikutaro Nakajima; Ryohsuke Narui; Kenichi Tokutake; Caleb A Norton; William G Stevenson; Travis D Richardson; Christopher R Ellis; George H Crossley; Jay A Montgomery Journal: Heart Rhythm Date: 2020-12-13 Impact factor: 6.343